Author(s)

Wangxiang Mai¹, Liang Fang², Zhuoming Chen¹, Xiuping Wang², Wanting Li¹, Weiyi He³

¹Department of Rehabilitation Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, China.
²Haizhu District Hospital of Traditional Chinese Medicine, Guangzhou, China.
³Department of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Objective: To explore the effects of the somatosensory interaction technology combined with virtual reality technology on upper limbs function and activities of daily living (ADL) in cerebrovascular disease patients. Methods: Form January, 2019 to December, 2019, 80 cerebrovascular disease patients were recruited, and had been divided into control group (n = 40) and observation group (n = 40), randomly. The control groups received conventional rehabilitation treatment, for 40 minutes per day, while observation group received conventional rehabilitation treatment, for 20 minutes per day, and virtual reality technology treatment, 20 minutes per day, 5 days a week for 4 weeks. Wolf Motor Function Test (WMFT), Fugl-Meyer Assessment-Upper Extremities (FMA-UE) and modified Barthel index (MBI) were used to assess the motor function of the upper limbs and ADL before and after treatment. Results: Before treatment, the scores of WMFT, FMA-UE and MBI were no significant difference between two groups (P > 0.05). The scores improved in both groups after treatment (P < 0.01), and were higher in the observation group than in the control group (P < 0.05). Conclusion: The somatosensory interaction technology combined with virtual reality technology could facilitate to improve the upper limbs function and ADL in cerebrovascular disease patients.

Cerebrovascular Disease, Somatosensory Interaction, Virtual Reality, Upper Limbs Function, Rehabilitation

Mai, W. , Fang, L. , Chen, Z. , Wang, X. , Li, W. and He, W. (2020) Application of the Somatosensory Interaction Technology Combined with Virtual Reality Technology on Upper Limbs Function in Cerebrovascular Disease Patients. Journal of Biomedical Science and Engineering, 13, 66-73. doi: 10.4236/jbise.2020.135006.